Pfizer Says Its Vaccine , Is Over 90% Effective Against COVID-19, in Children 5 to 11.
A recent study shows Pfizer's coronavirus
vaccine is 90.7% effective against
symptomatic COVID-19 in kids ages 5 to 11.
A Phase 2/3 trial found that the vaccine was safe and generated a strong antibody response in children.
The trial included
2,268 kids aged 5 to 11.
The immune response in
children was measured using
antibody levels in their blood.
Antibody levels were then compared
to a control group of 16 to 25-year-olds.
Children received two
doses of 10 micrograms.
Pfizer says antibody levels were comparable to adults who had received doses of 30 micrograms.
The FDA's Vaccine and Related Biological Products Advisory Committee will meet on October 26.
The Pfizer/BioNTech vaccine
has proven to be effective in adults.
An emergency use authorization
was recently granted to vaccinate
12 to 15-year-olds with Pfizer's vaccine